Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > New investors from the deal
View:
Post by SPCEO1 on Jan 19, 2021 11:42am

New investors from the deal

I have heard that three institutions accounted for 60% of the shares sold in the deal. That would give these three 10.8% or so of the company, Hopefully, they are long term holders and not in it just for the warrants. If these three have the same stakes, we may never learn who they are since I don't think they are required to report if they own below 5%.

I have an idea for the company to consider. It would seem fait to me if the company granted outright to all current shareholders the same warrant they just sold to the new investors. TH will need more money to complete the phase III NASH trial and the cash that would likely be derived from those warrants being exercised might take care of what they need three years from now. Better yet, make our warrants expire in two years.
Comment by JayjayUSA12007 on Jan 19, 2021 11:50am
SPCEO: "I have an idea for the company to consider. It would seem fait to me if the company granted outright to all current shareholders the same warrant they just sold to the new investors." That would be a good idea and fair. After all, Thera still needs more money to further its clinical trials. Would the number of warrants granted to existing shareholders be proportional to their ...more  
Comment by SPCEO1 on Jan 19, 2021 12:07pm
Whatever makes the most sense from a funding standpoint but I was thinking half a warrant for each share owned just like the new shareholders got. That would raise about $122 million if fully exercised in addition to the $27 million additional funds coming in from the warrants from the deal.  Obviously the terms could be adjusted (for example a lower exercise price) of the company does not ...more  
Comment by SABBOBCAT on Jan 19, 2021 12:11pm
Honestly, if they had granted existing shareholder s warrants, I would not be b!tching and moaning about the deal nearly as much. I was hoping to try and pick up some warrants, but they aren't listing.
Comment by Wino115 on Jan 19, 2021 12:20pm
the old way to do this would have been to grant existing shareholders each non traceable rights with whatever terms they want to put on them.  Would have been a hard sale to show such future dilution though and attract the new shareholders.    On those 3 new shareholders, I guess they were those "options" Paul said he had.  Let's just hope they are some new ...more  
Comment by palinc2000 on Jan 19, 2021 12:30pm
So about another 35 million new warrants which would give old time shareholders reason to sell their holdings  in the hope of participating  in any upside over the conversion  price ..... That would put a lid on the SP !!!!!
Comment by Wino115 on Jan 19, 2021 12:39pm
C'mon, let us dream big!  It is just a dream.  I suspect the only Thank you old shareholders will get is  top notch Smoked Meat and Poutine with truffles at the next in-person Annual.     
Comment by Bucknelly21 on Jan 19, 2021 12:54pm
There is already a lid on the sp because these guys don't know how to market the opportunity, always a couple months out when it comes to Thtx 
Comment by SPCEO1 on Jan 19, 2021 12:40pm
Hey, they are looking to get rid of us anyway I think! So, it even makes sense for management to accomplish their goal of neutrllizing the impact of this board by diversifying the list of shareholders! And warrants don't get to vote at the AGM, so it also protects their position if we were to sell our common shares and hold the warrants. It is a win/win for everyone!   Actually, I ...more  
Comment by palinc2000 on Jan 19, 2021 12:48pm
The biggest faults with the Offering is not the issue price ..... The BIGGEST  Faults are th e issue of warrants and   the Conversion Price .....This is outrageous  
Comment by SPCEO1 on Jan 19, 2021 12:50pm
That might be the biggest problem but everything about the deal was problematic. 
Comment by scarlet1967 on Jan 19, 2021 12:52pm
The company is supposed to support the valuation as the SP is well undervalued, how would they be able to attract new institutional and retail investors when they are millions of warrant issued, who would even consider investing in the company when they know the SP will be controlled by warrant holders in the next few years?
Comment by SPCEO1 on Jan 19, 2021 1:02pm
You may have noticed the presence of warrants, literally hundred of millions of warrants, has not hindered CYDY from seeing its s tock advance ina stratospheric way. More seriously, I am not sure that your concern, if I understand it correctly, is legitimate. The warrants are not goingt o control the share price. What is the difference if the company raises money via warrants converting or any ...more  
Comment by realitycheck4u on Jan 19, 2021 1:12pm
This post has been removed in accordance with Community Policy
Comment by qwerty22 on Jan 19, 2021 1:28pm
Remind me what your target price is say 1 year from now or 5 years
Comment by scarlet1967 on Jan 19, 2021 1:18pm
My point is they need to bring in midium to long term investors on board who are convinced to stay put which CYDY has managed but not our company due to marketing issue , apart from last few days the daily volume is nothing compared to CYDY so yes the damping effect of millions of warrants hanging about on a illiquid equity  with a company who can't market will be much more than CYDY. In ...more  
Comment by Wino115 on Jan 19, 2021 12:10pm
Good idea on a dividended warrant to old shareholders.  2 years and just set the strike at a 20% discount to the prevailing price in 2 years since that is what they cost us with their risk aversion.  Or, at that price and to exercise requires 5 warrants for 1 share, reflecting the 20% cost.  I like that!  
Comment by palinc2000 on Jan 19, 2021 1:36pm
IF that is a fact and I think this is a big IF they could have announced in one PR  a Private Placement for 10 million Units and a Public Offering for the remainder of the Units....The dilutive effect would have been the same but the optics and the perception would have been a lot different  
Comment by scarlet1967 on Jan 19, 2021 2:09pm
The shares of THTX due to lack of demand is illiquid and with low daily volume very volatile so we don't need traders who can with relatively small funds move it up and down on daily basis. That would only come across as a risky investment for any one who might consider buying the shares. The issue is marketing which needs to be fixed so we get more long term investors rather than traders who ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities